E50 (Etoposide 50 mg)
Pill with imprint E50 is Pink, Capsule-shape and has been identified as Etoposide 50 mg. It is supplied by Mylan Pharmaceuticals Inc..
Etoposide is used in the treatment of small cell lung cancer; ovarian cancer; testicular cancer; cancer; hodgkin's lymphoma and belongs to the drug class mitotic inhibitors. There is positive evidence of human fetal risk during pregnancy. Etoposide 50 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for E50
Etoposide
- Imprint
- E50
- Strength
- 50 mg
- Color
- Pink
- Size
- 23.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Mitotic inhibitors
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC)
- 00378-3266
- Inactive Ingredients
-
citric acid anhydrous, glycerin, polyethylene glycol, gelatin, ferric oxide red, titanium dioxide, FD&C Blue No. 1, FD&C Red No. 40, hypromelloses, propylene glycol
Note: Inactive ingredients may vary.
Related Images for "E50"
More about etoposide
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Pricing & Coupons
- Drug class: mitotic inhibitors
Consumer resources
- Etoposide
- Etoposide injection
- Etoposide phosphate
- Etoposide (Advanced Reading)
- Etoposide Oral, Intravenous (Advanced Reading)
- Etoposide Capsules
Other brands: VePesid, Toposar, Etopophos
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
